Preventing Stem Cell Transplant Complications With a Blood Separator Machine

Clinical trial NCT01866839 · COMPLETED

Trial details

NCT number: NCT01866839
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

MDS (Myelodysplastic Syndrome)Myeloproliferative Disorder Lymphoma, Non-Hodgkin ALL (Acute B-Lymphoblastic Leukemia)AML (Acute Myelogenous Leukemia

Start date: 2013-05-29
Primary completion: 2018-05-23
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.